Versigent director granted 5,168 ordinary shares
Versigent PLC director Brad M. Cerepak received a grant of 5,168 Ordinary Shares as equity compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Versigent PLC director Brad M. Cerepak received a grant of 5,168 Ordinary Shares as equity compensation. The shares were acquired on a non-cash basis at a reported price of $0.0000 per share. Following this award, he directly holds 5,168 Ordinary Shares, with no derivative positions reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Ordinary Shares | 5,168 | $0.00 | $0.00 |
Key Figures
Key Terms
Grant, award, or other acquisition financial
non-derivative financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Versigent (VGNT) report for Brad M. Cerepak?
Is the Brad M. Cerepak Form 4 for Versigent (VGNT) an open-market buy or a grant?
Does Brad M. Cerepak have any Versigent (VGNT) derivative positions reported in this filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.